Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
ABSTRACT
Circulating tumor cells drive metastasis when they travel from primary tumors to distant organs via the
circulation. Multicellular clusters of circulating tumor cells though less frequently observed in blood, are
much more likely to establish metastases than individual circulating tumor cells and the presence of tumor
clusters in blood has been associated with dramatically worse prognoses in patients. Although there are
many suspected explanations for their greater metastatic potentials, much is still unknown about the
behavior of clusters, especially in the narrow vessels of the body. Recent evidence has demonstrated that
cluster transiting through narrow constrictions experience dynamic changes to structure and organization.
Forces in the microcirculation cause clusters to reversibly re-organize into single-file chains to enable
transit through narrow capillary-sized vessels and nuclear envelopes are ruptured and rapidly repaired
during migration events through narrow constrictions. Two biophysical parameters within clusters,
cellular adhesion strengths and nuclear mechanics, are vital for these behaviors. Because of the important
role that these parameters play in many aspects of metastatic progression, we hypothesize that these
parameters modulate the biophysical responses of clusters to physical forces in the microcirculation, and
that these interactions play a significant role in the competitive edge that clusters have edge over
individual cancer cells for seeding metastases. To this end, we propose three specific aims. In aim 1, we
will develop next generation models of the human microcirculation with rounded networks of endothelial
cell coated microfluidic devices and geometry matched computational simulations. In aim 2, we will
explore how intercellular adhesions affect the biophysical responses and metastasis-forming abilities of
homogeneous versus heterogeneous clusters in the microcirculation through the use of our developed
models. Finally, in aim 3 we will study the physical basis for nuclear envelope rupture, DNA-damage,
genetic instability and other DNA-level affects that are involved in metastatic progression. Understanding
the interplay between the biophysics and biology of clusters within the microcirculation will elucidate
mechanisms that can be used to combat the progression of cluster-initiated metastases.
Public Health Relevance Statement
NARRATIVE
Multicellular aggregates of tumor cells are potent initiators of the progression of cancer from localized
tumors to multi-organ metastases by transiting through the circulation to establish metastases in distant
organs. Recent evidence has shown that the forces applied to cancer cells while they travel through the
smallest vessels of the body, cause dramatic changes to the behavior of adhesions and nuclei within
clusters and that these forces may be responsible for the increased potency of aggregates vs. single tumor
cells. We aim to study how physical forces interact with the biological components of clusters to initiate
metastasis and to devise methods of combating it.
No Sub Projects information available for 5U01CA214297-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01CA214297-05
Patents
No Patents information available for 5U01CA214297-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01CA214297-05
Clinical Studies
No Clinical Studies information available for 5U01CA214297-05
News and More
Related News Releases
No news release information available for 5U01CA214297-05
History
No Historical information available for 5U01CA214297-05
Similar Projects
No Similar Projects information available for 5U01CA214297-05